指南与共识神经MR

2024法国OFSEP多发性硬化MRI建议更新

Updated French OFSEP recommendations for multiple sclerosis MRI: alignment with the 2024 McDonald criteria.
指南 / 共识 · J Neuroradiol · 2026-06-06

法国OFSEP-SFNR多学科工作组采用类似改良Delphi法更新多发性硬化MRI建议,以对接2024 McDonald标准。核心脑协议包括各向同性3D FLAIR、DWI及优化的3D磁敏感序列以显示CVS和PRL,诊断时加做增强T1及眼眶协议。随访采用同一核心协议并限制钆剂使用。

要点

  • 视神经被列为第五个解剖部位,诊断时应加做眼眶MRI协议
  • 3D磁敏感序列用于评估中央静脉征和顺磁性环征
  • 随访使用相同核心协议,钆剂仅限特定适应证

核心结论

  • 这一厂商中立的框架有助于在多发性硬化诊断中更早、更特异,并减少法国各中心的钆剂使用。

研究设计与样本

  • 由OFSEP-SFNR多学科工作组采用类似改良Delphi法的共识流程制定。
  • 更新目标为在法国每一台1.5T和3T扫描仪上均可行。

关键影像表现/征象

  • 视神经被2024 McDonald标准认可为第五个解剖部位。
  • 中央静脉征和顺磁性环征被整合为特异性生物标志物。

诊断标准与关键数值

  • 核心脑协议包括各向同性脂肪抑制3D FLAIR(1 mm³)、DWI及ADC图。
  • 优化的3D磁敏感序列(3D T2* GRE或带滤波相位的3D SWI)用于显示CVS和PRL。
  • 诊断时添加对比增强3D自旋回波T1序列和疑似视神经炎的专用眼眶协议。
  • 脊髓协议包括至少两个互补序列,可用时加高对比重T1加权序列。
  • 随访使用同一核心协议,3D FLAIR需严格可重复,钆剂限于特定适应证。

临床应用与阅片要点

  • 日常报告应关注3D FLAIR的新病灶及3D磁敏感序列的CVS和PRL征象。
  • 诊断疑似视神经炎时需要额外完成眼眶扫描而不是仅做常规头颅扫描。
  • 随访扫描应保持3D FLAIR序列参数一致以可靠比较病灶变化。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

BACKGROUND: Magnetic resonance imaging (MRI) is central to the diagnosis and follow-up of multiple sclerosis (MS). Since the 2020 OFSEP recommendations, the 2024 McDonald criteria have introduced major changes, including recognition of the optic nerve as a fifth anatomical topography and integration of two specificity biomarkers - the central vein sign (CVS) and the paramagnetic rim lesion (PRL).

OBJECTIVE: To update the French OFSEP MRI recommendations for MS while remaining feasible on every 1.5 T and 3 T scanner in France.

METHODS: A multidisciplinary OFSEP-SFNR working group conducted a modified Delphi-like consensus process.

RECOMMENDATIONS: The core brain protocol comprises isotropic fat-suppressed 3D FLAIR (1 mm³), DWI with ADC maps, and an optimised 3D susceptibility-sensitive sequence (3D T2* GRE or 3D SWI with filtered phase) for CVS and PRL. A contrast-enhanced 3D spin-echo T1 sequence and a dedicated orbital protocol for suspected optic neuritis are added at diagnosis. The spinal cord protocol includes at least two complementary sequences, with a high-contrast heavily T1-weighted sequence when available. Follow-up uses the same core protocol with strictly reproducible 3D FLAIR; gadolinium is restricted to targeted indications.

CONCLUSION: This vendor-neutral framework supports earlier, more specific MS diagnosis and reduced gadolinium use across French centres.

来源:J Neuroradiol,查看原文。版权归原作者所有。

引用

  1. Lecler, Mondot, Homo, et al. Updated French OFSEP recommendations for multiple sclerosis MRI: alignment with the 2024 McDonald criteria. J Neuroradiol. 2026. PMID: 42250869. doi:10.1016/j.neurad.2026.101576

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。